US Stock MarketDetailed Quotes

SLDB Solid Biosciences

Watchlist
  • 4.9100
  • +0.2300+4.91%
Close Dec 13 16:00 ET
  • 4.6700
  • -0.2400-4.89%
Post 20:01 ET
196.18MMarket Cap-1.62P/E (TTM)

About Solid Biosciences Company

Solid Biosciences, Inc. is a life science company, which engages in the development of treatments for patients with Duchenne muscular dystrophy. It also focuses on developing treatments for neuromuscular and cardiac diseases. The company was founded by Ilan Ganot, Andrey J. Zarur, Matthew Bennett Arnold, Annie Ganot, and Gilad David Hayeem in March 2013 and is headquartered in Charlestown, MA.

Company Profile

SymbolSLDB
Company NameSolid Biosciences
Listing DateJan 26, 2018
Issue Price16.00
Founded2013
CEOMr. Alexander G. Cumbo
MarketNASDAQ
Employees88
Fiscal Year Ends12-31
Address500 Rutherford Avenue,3rd floor
CityCharlestown
ProvinceMassachusetts
CountryUnited States of America
Zip Code02129
Phone1-617-337-4680
Websitehttp://www.solidbio.com

Company Executives

  • Name
  • Position
  • Salary
  • Alexander G. Cumbo
  • President, Chief Executive Officer and Director
  • 918.55K
  • Dr. Jennifer Marlowe, PhD
  • Chief Scientific Officer
  • --
  • Dr. Gabriel Brooks, M.D.
  • Chief Medical Officer
  • --
  • Kevin Tan
  • Treasurer, Chief Financial Officer and Principal Accounting Officer
  • 1.35M
  • David Tyronne Howton
  • Chief Operating Officer, General Counsel and Secretary
  • 648.88K
  • Dr. Jessie Hanrahan, PhD
  • Chief Regulatory Officer
  • --
  • Dr. Paul Herzich, PhD
  • Chief Technology Officer
  • --
  • Ian F. Smith
  • Executive Chairman of the Board
  • 828.65K
  • Ilan Ganot
  • Director
  • 902.09K
  • Rajeev Shah
  • Independent Director
  • 104.22K
  • Dr. Sukumar Nagendran, M.D.
  • Independent Director
  • 106.72K
  • Dr. Georgia Keresty, M.P.H.,PhD
  • Independent Director
  • 101.72K
  • Lynne Sullivan
  • Independent Director
  • 113.22K
  • Dr. Clare Kahn, PhD
  • Independent Director
  • 105.72K
  • Adam Stone
  • Lead Independent Director
  • 109.72K
  • Dr. Martin Freed, F.A.C.P.,M.D.
  • Independent Director
  • 114.22K
  • Dr. Adam M. Koppel, M.D.,PhD
  • Independent Director
  • 94.22K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Tesla
TSLA
+4.34%
MicroStrategy
MSTR
+4.20%
MARA Holdings
MARA
+0.66%
Apple
AAPL
+0.07%
Microsoft
MSFT
-0.51%

Unlock the Full List